Manipal Health Q2 FY27 net profit falls 13% to ₹270 crore despite 37% revenue surge
Synopsis
Manipal Health's Q2 FY27 headline profit fell 13% to ₹270 crore — but strip out acquisition-related financing costs and the picture flips: adjusted PAT surged 45.6% to ₹455 crore. The Sahyadri acquisition is reshaping the company's scale, but the real test is how fast it converts a 37% revenue jump into sustainable margin recovery.
Key Takeaways
Manipal Health Enterprises reported Q2 FY27 net profit of ₹270 crore , down 13.2% year-on-year from ₹311 crore .
Revenue from operations jumped 37.3% to ₹3,399 crore , driven partly by the consolidation of Sahyadri Hospitals acquired in October 2025 .
EBITDA rose 29.8% to ₹872 crore , though EBITDA margin narrowed to 26% from 27% .
Adjusted PAT excluding exceptional items stood at ₹380 crore (up 21.6% ); further adjusted for NCD interest, PAT was ₹455 crore (up 45.6% ).
Inpatient volumes rose 35% ; outpatient volumes climbed 27.2% year-on-year; occupancy improved to 70.1% .
Licensed bed capacity expanded to 13,440 with the new Electronic City hospital in Bengaluru .
Manipal Health Enterprises Limited reported a 13.2% year-on-year decline in net profit for the second quarter of FY27, with profit dropping to ₹270 crore from ₹311 crore in Q2 FY26, according to its stock exchange filing. The dip in bottomline came even as the healthcare major posted strong revenue growth, underscoring the cost pressures that accompanied its recent acquisition-led expansion.
Revenue and EBITDA Growth
Revenue from operations surged 37.3% year-on-year to ₹3,399 crore for the quarter ended September 2026, up from ₹2,475 crore in the corresponding quarter last year. Earnings before interest, taxes, depreciation and amortisation (EBITDA) grew 29.8% year-on-year to ₹872 crore, although the EBITDA margin narrowed slightly to 26% from 27% in the prior-year period — a compression that analysts may attribute to integration costs from the Sahyadri acquisition.
Profit Picture: Exceptional Items and Adjustments
The company reported a profit after tax (PAT) of ₹285 crore for the quarter. Excluding exceptional items, PAT stood at ₹380 crore, representing a 21.6% year-on-year increase. When further adjusted to exclude post-tax interest on non-convertible debentures raised to fund the Sahyadri Hospitals acquisition, PAT reached ₹455 crore — a 45.6% jump — offering a cleaner read on underlying operational performance.
Sahyadri Acquisition Shapes Results
The current consolidated numbers include contributions from Sahyadri Hospitals, acquired in October 2025, which was not part of the prior-year comparison base. This acquisition effect accounts for a significant portion of the top-line and volume growth, making direct year-on-year comparisons less straightforward. For the first half of FY27, Manipal Health's revenue climbed 37.7% year-on-year to ₹6,490 crore, while EBITDA grew 28.2% to ₹1,631 crore. Excluding a one-off gain recorded in H1 FY26, EBITDA growth stood at 29.8%.
Operational Metrics and Capacity Expansion
Operating performance was supported by robust volume growth, with inpatient volumes rising 35% and outpatient volumes climbing 27.2% year-on-year. Occupancy rates improved to 70.1%, with the company operating an average capacity of 7,331 beds and an average length of stay of 2.8 days. The company also expanded its licensed bed capacity to 13,440 with the opening of its Electronic City hospital in Bengaluru.
Stock Performance
Shares of Manipal Health Enterprises Limited closed at ₹680 on Friday, up 0.48% on the Bombay Stock Exchange (BSE). The muted market reaction suggests investors are likely weighing the acquisition-driven cost overhang against the strong revenue trajectory. With bed capacity expanding and volumes accelerating, the company's ability to convert top-line momentum into profitability will be the key metric to watch in coming quarters.
Point of View
Which is a materially different story. The real concern is margin compression: a 100-basis-point EBITDA margin dip on a 37% revenue surge suggests integration and capacity costs are running ahead of synergies. Manipal Health's expansion to 13,440 licensed beds is strategically sound in a sector with chronic under-supply, but the market will demand a credible timeline for when that capacity translates into margin recovery — not just volume growth.
NationPress
14 Nov 2026
Frequently Asked Questions
Why did Manipal Health's net profit fall in Q2 FY27?
Manipal Health's net profit fell 13.2% to ₹270 crore in Q2 FY27 primarily due to higher financing costs, including interest on non-convertible debentures raised to fund the Sahyadri Hospitals acquisition in October 2025. Excluding these costs and exceptional items, adjusted profit rose significantly.
What was Manipal Health's revenue in Q2 FY27?
Revenue from operations grew 37.3% year-on-year to ₹3,399 crore for the quarter ended September 2026, compared to ₹2,475 crore in Q2 FY26. The growth was partly driven by the consolidation of Sahyadri Hospitals, which was not part of the prior-year base.
What is the Sahyadri Hospitals acquisition and how did it affect results?
Sahyadri Hospitals was acquired by Manipal Health Enterprises in October 2025, and its revenues and operations are now consolidated into Manipal's quarterly results for the first time. This acquisition inflated both revenue and volume growth figures relative to the prior year, while also adding financing costs that weighed on reported net profit.
How did Manipal Health's operational volumes perform in Q2 FY27?
Inpatient volumes rose 35% and outpatient volumes grew 27.2% year-on-year. Occupancy rates improved to 70.1%, with an average capacity of 7,331 beds and an average length of stay of 2.8 days.
What is Manipal Health's new hospital expansion?
Manipal Health opened a new hospital in the Electronic City area of Bengaluru, expanding its licensed bed capacity to 13,440. This is part of the company's broader strategy to scale capacity across key urban markets in India.
